↓ Skip to main content

BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma

Overview of attention for article published in Cancer and Metastasis Reviews, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
46 Mendeley